100841-04-1 Usage
General Description
3-(4-Nitrophenoxy)propylamine is a chemical compound with the molecular formula C9H12N2O3. It is often used in chemical and pharmaceutical research due to its versatile characteristics. The compound is an organic-derivative associated with its nitroaromatic compound, having both amine and ether functionalities. The nitro group in this chemical makes its presence more reactive, while the presence of the propylamine group provides a versatile site for further chemical transformations. Although it does not occur naturally, it can be synthesized in a laboratory setting. Like many chemicals, it requires careful handling, and exposure should be minimized due to potential harmful or toxic effects.
Check Digit Verification of cas no
The CAS Registry Mumber 100841-04-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,0,8,4 and 1 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 100841-04:
(8*1)+(7*0)+(6*0)+(5*8)+(4*4)+(3*1)+(2*0)+(1*4)=71
71 % 10 = 1
So 100841-04-1 is a valid CAS Registry Number.
InChI:InChI=1/C9H12N2O3/c10-6-1-7-14-9-4-2-8(3-5-9)11(12)13/h2-5H,1,6-7,10H2
100841-04-1Relevant articles and documents
LIQUID CRYSTAL ALIGNING AGENT
-
, (2016/10/08)
Provided is a liquid crystal aligning agent capable of forming a liquid crystal alignment film the surface of which is rarely scratched or abraded when rubbed, and which exhibits excellent liquid crystal aligning properties and enables the production of l
Discovery of TD-4306, a long-acting β2-agonist for the treatment of asthma and COPD
McKinnell, R. Murray,Klein, Uwe,Linsell, Martin S.,Moran, Edmund J.,Nodwell, Matthew B.,Pfeiffer, Juergen W.,Thomas, G. Roger,Yu, Cecile,Jacobsen, John R.
, p. 2871 - 2876 (2014/06/10)
A multivalent approach focused on amine-based secondary binding groups was applied to the discovery of long-acting inhaled β2-agonists. Addition of amine moieties to the neutral secondary binding group of an existing β2-agonist serie
Irreversible enzyme inhibitors. CLV. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 1-[4-(omega-aminoalkoxy)-3-chlorophenyl]-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazines bearing a terminal sulfonyl fluoride.
Baker,Janson
, p. 672 - 676 (2007/10/06)
-